BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kulkarni U, Mathews V. Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia. Front Oncol 2021;11:621566. [PMID: 33718181 DOI: 10.3389/fonc.2021.621566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Dancik GM, Voutsas IF, Vlahopoulos S. Lower RNA expression of ALDH1A1 distinguishes the favorable risk group in acute myeloid leukemia. Mol Biol Rep 2022. [PMID: 35028852 DOI: 10.1007/s11033-021-07073-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Dancik GM, Voutsas IF, Vlahopoulos S. Lower RNA expression of ALDH1A1 distinguishes the favorable risk group in acute myeloid leukemia.. [DOI: 10.1101/2021.10.20.21265241] [Reference Citation Analysis]
3 Khamidullina AI, Varlamova EA, Hammoud NA, Yastrebova MA, Bruter AV. Gene Transcription as a Therapeutic Target in Leukemia. Int J Mol Sci 2021;22:7340. [PMID: 34298959 DOI: 10.3390/ijms22147340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]